JGP Global Gestao de Recursos’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,305
Closed -$216K 54
2023
Q3
$216K Sell
2,305
-12
-0.5% -$1.12K 0.14% 43
2023
Q2
$207K Sell
2,317
-8
-0.3% -$696 0.14% 59
2023
Q1
$249K Buy
2,325
+49
+2% +$5.61K 0.26% 43
2022
Q4
$278K Sell
2,276
-2
-0.1% -$232 0.2% 47
2022
Q3
$235K Buy
2,278
+1
+0% +$95 0.2% 45
2022
Q2
$212K Sell
2,277
-7
-0.3% -$660 0.16% 50
2022
Q1
$268K Buy
2,284
+101
+5% +$11.7K 0.15% 49
2021
Q4
$294K Sell
2,183
-1
-0% -$149 0.14% 50
2021
Q3
$348K Sell
2,184
-287
-12% -$39.3K 0.13% 53
2021
Q2
$325K Buy
2,471
+140
+6% +$18.7K 0.11% 50
2021
Q1
$300K Sell
2,331
-1,188
-34% -$181K 0.19% 41
2020
Q4
$587K Sell
3,519
-65
-2% -$10.7K 2.21% 14
2020
Q3
$553K Sell
3,584
-91
-2% -$13.1K 0.3% 28
2020
Q2
$544K Hold
3,675
0.32% 26
2020
Q1
$414K Buy
3,675
+270
+8% +$35.1K 0.18% 37
2019
Q4
$474K Buy
3,405
+45
+1% +$5K 0.17% 40
2019
Q3
$324K Buy
3,360
+379
+13% +$42.3K 0.18% 47
2019
Q2
$343K Buy
+2,981
New +$357K 0.13% 36

Other funds holding ASND

JGP Global Gestao de Recursos's ASND Position: Q4 2023 in Review

JGP Global Gestao de Recursos sold out of Ascendis Pharma A/S (ASND) in Q4 2023, closing a stake of 2,305 shares — an estimated $216K sold.

JGP Global Gestao de Recursos first reported a position in ASND in Q2 2019 and held it in 18 quarters. The position peaked at $587K in Q4 2020. 185 funds tracked by Wall St. Rank hold ASND as of Q4 2023.

  • JGP Global Gestao de Recursos reported no remaining Ascendis Pharma A/S position as of Q4 2023 after selling out during the quarter.
  • JGP Global Gestao de Recursos sold 2,305 Ascendis Pharma A/S shares in Q4 2023, an estimated $216K.
  • JGP Global Gestao de Recursos first reported a position in Ascendis Pharma A/S in Q2 2019 and held it in 18 quarters.
  • JGP Global Gestao de Recursos's Ascendis Pharma A/S position peaked at $587K in Q4 2020.
  • 185 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2023.

Based on JGP Global Gestao de Recursos's 13F filing for Q4 2023, filed 19 Jan 2024.